Literature DB >> 10673708

FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation.

A Misawa1, Y Takeuchi, S Hibi, S Todo, S Imashuku, T Sawada.   

Abstract

FK506-related leukoencephalopathy has been reported to be reversible and readily treated by discontinuation or reduction of FK506. We describe two pediatric cases of FK506-related leukoencephalopathy following allogeneic bone marrow transplantation, which could not be readily controlled. These cases show that FK506-related leukoencephalopathy is not always reversible, and patients may develop epilepsy. Bone Marrow Transplantation (2000) 25, 331-334.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10673708     DOI： 10.1038/sj.bmt.1702143

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  3 in total

1.  Tacrolimus-related encephalopathy following allogeneic stem cell transplantation in children.

Authors:  Takahisa Kanekiyo; Junichi Hara; Yoshiko Matsuda-Hashii; Hiroyuki Fujisaki; Sadao Tokimasa; Akihisa Sawada; Keiko Kubota; Kuriko Shimono; Katsumi Imai; Keiichi Ozono
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

2.  Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression.

Authors:  C Horbinski; W S Bartynski; E Carson-Walter; R L Hamilton; H P Tan; S Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-14       Impact factor: 3.825

3.  Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation.

Authors:  Marjan Chegounchi; Michael G Hanna; Guy H Neild
Journal:  BMC Nephrol       Date:  2006-03-31       Impact factor: 2.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.